Treatment Challenges in Multiple Sclerosis – A Continued Role for Glatiramer Acetate?

Earlier diagnosis, access to disease-modifying therapies (DMTs), and improved supportive care have favorably altered the disease course of multiple sclerosis (MS), leading to an improvement in long-term outcomes for people with MS (PwMS). This success has changed the medical characteristics of the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirabella, Massimiliano, Annovazzi, Pietro, Brownlee, Wallace, Cohen, Jeffrey A., Kleinschnitz, Christoph, Wolf, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051342/
https://www.ncbi.nlm.nih.gov/pubmed/35493825
http://dx.doi.org/10.3389/fneur.2022.844873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051342/
https://www.ncbi.nlm.nih.gov/pubmed/35493825
http://dx.doi.org/10.3389/fneur.2022.844873

Ejemplares similares